Page last updated: 2024-10-25

ciclopirox and Leukemia, Myeloid, Acute

ciclopirox has been researched along with Leukemia, Myeloid, Acute in 2 studies

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sen, S1
Hassane, DC1
Corbett, C1
Becker, MW1
Jordan, CT1
Guzman, ML1
Eberhard, Y1
McDermott, SP1
Wang, X1
Gronda, M1
Venugopal, A1
Wood, TE1
Hurren, R1
Datti, A1
Batey, RA1
Wrana, J1
Antholine, WE1
Dick, JE1
Dick, J1
Schimmer, AD1

Trials

1 trial available for ciclopirox and Leukemia, Myeloid, Acute

ArticleYear
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
    Experimental hematology, 2013, Volume: 41, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cell Line, Tumor; Ciclopirox; Drug Syner

2013

Other Studies

1 other study available for ciclopirox and Leukemia, Myeloid, Acute

ArticleYear
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
    Blood, 2009, Oct-01, Volume: 114, Issue:14

    Topics: Animals; Antifungal Agents; Antimetabolites, Antineoplastic; Apoptosis; Cells, Cultured; Ciclopirox;

2009